Carlos David Freitas De Sousa

Managing Director

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
1
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity Dec 8, 2016 – Aug 29, 2019

Carlos David Freitas De Sousa reported 19 transactions between Dec 8, 2016 and Aug 29, 2019. The buy and sell totals below count only code SACQ.

Open-market buys (SACQ)
1.34M SEK
18 purchases on file priced rows only
Open-market sales
None
0 sales on file
All reported transactions
19
every code, including awards and exercises
Pattern
No transaction in the final 12 months of the window
last 12 months of the window

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 19 most recent rows are grouped into 13 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Immunicum AB SACQ Acquisition 10,000 shares 86.0K SEK at 8.60 SEK FI filing ↗
  2. Immunicum AB SACQ Acquisition 691,931 shares 240.1K SEK at 0.35 SEK FI filing ↗
  3. Immunicum AB SACQ Acquisition × 2 5,878 shares 45.2K SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    2,193 7.69 SEK 16.9K SEK FI filing ↗
    3,685 7.70 SEK 28.4K SEK FI filing ↗
  4. Immunicum AB SSUB Subscriptionnot a buy/sell decision 56,892 shares 483.6K SEK at 8.50 SEK FI filing ↗
  5. Immunicum AB SACQ Acquisition 10,000 shares 70.0K SEK at 7.00 SEK FI filing ↗
  6. Immunicum AB SACQ Acquisition 10,000 shares 68.9K SEK at 6.89 SEK FI filing ↗
  7. Immunicum AB SACQ Acquisition × 3 10,000 shares 67.8K SEK
    The 3 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    7,394 6.79 SEK 50.2K SEK FI filing ↗
    1,550 6.78 SEK 10.5K SEK FI filing ↗
    1,056 6.75 SEK 7.1K SEK FI filing ↗
  8. Immunicum AB SACQ Acquisition × 2 10,000 shares 68.4K SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    3,663 6.85 SEK 25.1K SEK FI filing ↗
    6,337 6.84 SEK 43.3K SEK FI filing ↗
  9. Immunicum AB SACQ Acquisition 73,560 shares 592.2K SEK at 8.05 SEK FI filing ↗
  10. Immunicum AB SACQ Acquisition × 2 20,000 shares 4.0K SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    19,563 0.20 SEK 3.9K SEK FI filing ↗
    437 0.16 SEK 70 SEK FI filing ↗
  11. Immunicum AB SACQ Acquisition 2,000 shares 49.9K SEK at 24.94 SEK FI filing ↗
  12. Immunicum AB SACQ Acquisition × 2 1,933 shares 43.4K SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    1,000 22.49 SEK 22.5K SEK FI filing ↗
    933 22.40 SEK 20.9K SEK FI filing ↗
  13. Immunicum AB SACQ Acquisition 100 shares 2.2K SEK at 22.49 SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
Immunicum AB SE0005003654 IMMU 59,911 — — FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Carlos David Freitas De Sousa reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.